We have developed a rapid [H-3]colchicine competition-binding scintillation
proximity assay (SPA) to evaluate antimitotic compounds that bind to the c
olchicine-binding site on tubulin. The premise of our assay is that compoun
ds will compete with radiolabeled colchicine for the tubulin-binding domain
. Biotin-labeled tubulin is incubated first with unlabeled compound and rad
iolabeled ligand Streptavidin-labeled SPA beads are added, and the radiolab
el associated with tubulin is directly counted with no separation steps. Un
der our experimental conditions, the dissociation constant of binding (K-d)
for colchicine to tubulin was determined to be 1.4 mu M, which was consist
ent with previously reported values. Assay validation was performed by comp
etitively inhibiting [H-3]colchicine binding to tubulin with known microtub
ule inhibitors and comparing their inhibition constants (K-i). Our SPA bead
method is a powerful tool since it overcomes the disadvantage of tradition
al filtration techniques, as there are no separation steps. It is extremely
easy to set lip, multiple samples can be assayed and supply and labor cost
s are reduced because of the minimal volume and test reagents used.